Dong Liang, Chen Yu, Zhao Ma, Xingye Yang, Zhenzhen Li, Xuhui Dong, Xiaojun Qin, Lupei Du, Minyong Li. Author correction to “Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning” Acta Pharm Sin B 12 (2022) 2429-2442J. Acta Pharmaceutica Sinica B, 2024, 14(11): 5089-5090. DOI: 10.1016/j.apsb.2024.09.006
|
Citation:
|
Dong Liang, Chen Yu, Zhao Ma, Xingye Yang, Zhenzhen Li, Xuhui Dong, Xiaojun Qin, Lupei Du, Minyong Li. Author correction to “Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning” Acta Pharm Sin B 12 (2022) 2429-2442J. Acta Pharmaceutica Sinica B, 2024, 14(11): 5089-5090. DOI: 10.1016/j.apsb.2024.09.006
|
Dong Liang, Chen Yu, Zhao Ma, Xingye Yang, Zhenzhen Li, Xuhui Dong, Xiaojun Qin, Lupei Du, Minyong Li. Author correction to “Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning” Acta Pharm Sin B 12 (2022) 2429-2442J. Acta Pharmaceutica Sinica B, 2024, 14(11): 5089-5090. DOI: 10.1016/j.apsb.2024.09.006
|
Citation:
|
Dong Liang, Chen Yu, Zhao Ma, Xingye Yang, Zhenzhen Li, Xuhui Dong, Xiaojun Qin, Lupei Du, Minyong Li. Author correction to “Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning” Acta Pharm Sin B 12 (2022) 2429-2442J. Acta Pharmaceutica Sinica B, 2024, 14(11): 5089-5090. DOI: 10.1016/j.apsb.2024.09.006
|